• Exchange: Canadian Sec
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pacific Therapeutics Ltd

+ Add to Watchlist


0.0400 CAD 0.0150 27.27%

As of 15:43:34 ET on 09/18/2014.

Snapshot for Pacific Therapeutics Ltd (PT)

Open: 0.0450 Day's Range: 0.0400 - 0.0450 Volume: 95,000
Previous Close: 0.0550 52wk Range: 0.0100 - 0.1550 1-Yr Rtn: -20.00%

Stock Chart for PT

No chart data available.
  • PT:CN 0.0400
  • 1D
  • 1M
  • 1Y
Interactive PT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 1.06
Shares Outstanding (M) 26.59
30 Day Average Volume 22,873
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PT

No data available

Company Profile & Key Executives for PT

Pacific Therapeutics Ltd. is a development stage specialty pharmaceutical company. The Company is involved in the identification and development of drug candidates to treat diseases of excessive scarring including Idiopathic Pulmonary Fibrosis.

M Greg BenistonChairmanDouglas H UnwinPresident/CEO
Derick Graham SinclairCFO/Secretary
More Company Profile & Key Executives for PT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • PT News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil